55 results about "Acupoint injection" patented technology

The invention discloses an acupoint injection device for skin care. The device comprises a cylinder body, wherein an opening is formed in one end of the cylinder body, and the other end has a sealed structure; the opened end of the cylinder body is penetrated and equipped with a connecting rod; a handle is disposed on the connecting rod tail end which is located outside the cylinder body; a piston is connected to the connecting rod tail end which is located inside the cylinder body; a syringe needle base communicating with the cylinder body is disposed on a sealed end of the cylinder body; the tail end of the syringe needle base is in a threaded connection with a syringe needle; a sealed end of the syringe needle base is connected to a nursing disk by a hydraulic expansion-type rod; a through hole is formed in the middle part of the surface of the nursing disk; the syringe needle passes through the through hole and is exposed to exterior of the through hole; massage raised parts which are arranged annularly are disposed on the surface of the nursing disk around the through hole; a pressing switch is disposed on the surface edge of the nursing disk; and an electric heating wire, a magnetic therapy block and a storage battery are disposed in the inner chamber of the nursing disk. The acupoint injection device for the skin device has the advantages that massage, heating and magnetic therapy can be conducted during medicine injection; and the device has multiple functions and makes for the skin care.

The invention discloses a drug for treating lumbar intervertebral disc herniation with pain. The drug consists of the following ingredients in portions by weight: 20-40 portions of carthamus tinctorius, 20-40 portions of cortex acanthopanacis, 10-30 portions of rhizoma alpiniae officinarum, 10-20 portions of Chinese angelica, 20-30 portions of caulis sinomenii, 20-40 portions of erythrina bark, 20-30 portions of rhizoma corydalis, 20-30 portions of codonopsis pilosula, 10-20 portions of cortex lycii radicis, 10-30 portions of radix aucklandiae, 20-40 portions of salvia miltiorrhiza, 20-40 portions of caulis trachelospermi, 10-20 portions of radix stephaniae tetrandrae, 20-40 portions of ligusticum wallichii, 10-30 portions of salt eucommia, 20-40 portions of cortex ailanthi, 20-40 portions of achyranthes bidentata, 20-40 portions of poria cocos, 20-40 portions of caulis piperis futokadsurae, 20-40 portions of radix clematidis and 10-20 portions of herba epimedii. The above medicines are added to 5000 portions of 30-40 DEG liquor to be sealed and stored for one month, and the liquor containing traditional Chinese medicine is poured out after dregs are removed. The curative effect of the drug is better than the curative effects of acupuncture and moxibustion, massage, acupoint injection and other traditional Chinese medicines.

The invention discloses a traditional Chinese medicine perfusion fluid which comprises the following components in parts by weight: 80 parts of herba epimedii, 60 parts of actinolite, 60 parts of salviae miltiorrhizae, 60 parts of flos carthami, 60 parts of leonurus, 60 parts of angelica sinensis, 60 parts of astragalus membranaceus, 60 parts of semen cuscutae and 60 parts of peach kernels. The invention further provides a preparation method and application of the perfusion fluid. The perfusion fluid disclosed by the invention has the beneficial effects that (1) according to the actual production requirements of cattle rearing industry, a novel formula is formed to effectively solve the key link in actual production of cattle rearing industry: the ovary disease infertility of cows suitable for reproduction, so that the conception rate in estrus of cows suitable for reproduction is improved, and the conception rate reaches up to 82.04%; (2) according to the Chinese veterinarian acupoint theory, the medicine gives the maximum effect by different delivery manners: uterus perfusion or acupoint injection; (3) a novel preparation which not only can be perfused in uterus but also can be injected from acupoints is refined by virtue of a water extract and alcohol precipitate method by means of a modern pharmaceutical preparation technology, so that the existing production process is improved, and the purpose of quality control can be realized.

The invention discloses an acupoint injection medicine for treating rheumatic arthralgia, a preparation method and an application, which relates to the medicine technical field of rheumatic arthralgia treatment. The invention provides the medicine for treating rheumatic arthralgia with the advantages of safe and effective performance, and the preparation method and the application. The acupoint injection medicine for treating rheumatic arthralgia comprises the following raw materials by volume ratio: 2-3 parts of Daphne giraldii Nitsche injection, 2-3 parts of gen-seng injection, 2-3 parts of saussurea involucrata injection, 2-3 parts of clematis root injection, 2-3 parts of no injection in summer and 2-3 parts of injection in winter. The prepared disinfection aqueous solution of the medicine raw materials are mixed according to volume ratio to prepare the acupoint injection medicine. The acupoint injection medicine for treating rheumatic arthralgia is used for purifying blood, treating various rheumatic arthralgia and other rheumatism illness. The application method of the medicine is acupoint injection, and the acupoint injection medicine is capable of integral adjusting, and has the functions of qi-blood interacting, nourishing liver and kidney, reinforcing bone and nourishing marrow, invigorating spleen and disinhibiting dampness, promoting blood circulation to remove blood stasis, and diminishing flammation and relieving pain. The medicine is safe and effective, and can thoroughly treat various rheumatic arthralgia and difficult illness.

The invention belongs to the field of traditional Chinese medicines, and particularly relates to dicranostigma leptopodum injection and preparation method thereof. The dicranostigma leptopodum injection is prepared from a dicranostigma leptopodum extracting solution which is an active drug, and the dicranostigma leptopodum extracting solution is obtained by extracting through alcohol extraction and water precipitation, eluting and purifying through a resin column, and finally adding auxiliary materials. By the dicranostigma leptopodum injection, the blood glucose level of mice can be reduced remarkably, and further experiments show that by acupoint injection of the dicranostigma leptopodum injection, diabetic foot can be treated remarkably.

An acupoint injecting method for treating the diseases features that the relative medicine is injected to the acupoint(s) associated with the disease for treating it. Its advantages are high curative effect, quickly taking its effect, low dosage, short course of treatment and low cost.

An application of the steroid-type pregnanolone and its isomer in preparing the medicine in the form of orally applied medicine, injection, or table for treating hypertension is disclosed. Its advantages are high curative effect and low toxic by-effect.

The invention belongs to the field of medicines and relates to a medicine preparation for treating myasthenia gravis. The pharmaceutical preparation of the present invention comprises medicinal sodium thiosulfate of effective therapeutic dose, and pharmaceutically acceptable pharmaceutical auxiliary materials. The pharmaceutical preparation is injection solution or powder injection for acupoint injection. The pharmaceutical preparation of the present invention can cure patients with myasthenia gravis under the guidance of the treatment concept of integrated traditional Chinese and western medicine, and has quick effect, good curative effect, safety, short course of treatment, no recurrence after healing, and is easy to produce industrially, and is suitable for clinical application .

The invention provides a traditional Chinese medicinal composition freeze-drying injection and a preparation method thereof. The traditional Chinese medicament freeze-drying injection is prepared from raw materials comprising ginseng and epimedium herb by extraction and refinement of a modern process and then by a freeze-drying process. The traditional Chinese medicament preparation meets technical requirements of the State Food and Drug Administration (SFDA) on the traditional Chinese medicament injection and is clinically applied to treatment on amyotrophy and myasthenia gravis caused by diseases such as motor neuron diseases (amyotrophic lateral sclerosis, progressive spinal muscular atrophy, progressive bulbar palsy and primary lateral sclerosis), progressive myodystrophy, congenital myopathy and the like. The traditional Chinese medicament freeze-drying injection is administrated clinically through intravenous, intramuscular or acupoint injection.

The invention provides the application of brain tissue fluid and nerve growth factor which are used to prepare drug combinations for treating children's cerebral pasly. The invention provides the drug combinations of the brain fluid and the nerve growth factor. The route of medication of the drug combinations is that the drug is injected through channels and then through outer odd acupuncture point. The drug combination has the advantages of being capable of adjusting brain cells of children patients to regenerate, activate and restore injured and oxygen-poor brain cells, also being capable of effectively restoring functional disturbances of intelligence, language, motion and behavior, having distinguished therapeutic and curative effects. The drug provides a very unique and effective choice for the treatment and rehabilitation treatment work of the children's cerebral pasly, ensuring the children patients who are infected with cerebral pasly to improve the quality of life and survivorship, thereby reducing mental and economic burdens of society and families.

The invention provides an analgesic, prepared from the following raw materials: radix stephaniae tetrandrae, herba speranskiae tuberculatae, rhizoma corydalis, fructus evodiae, trogopterus dung, myrrh, sea cucumber, rhizoma smilacis glabrae, tabasheer, pine nodular branch, radix clematidis, Chinese angelica, radix paeoniae alba, raw liquorice root, borneol, rhizoma curcumae, semen coicis, raw rhizoma atractylodis macrocephalae and herba cistanche. The traditional Chinese medicine preparation is provided on this basis; by means of a great deal of clinical medication observation, laboratory studies and relevant safety testing, the traditional Chinese medicine preparation provided by the invention is proved to be precise and appropriate in prescription formulation and compatibility, definite in treatment effect, safe and reliable, and is clinically promoted in a dosage form of acupoint injection, thus bringing good news to patients beset by the pain of various bone diseases.

The invention belongs to the field of traditional Chinese medicines, and particularly relates to dicranostigma leptopodum injection and preparation method thereof. The dicranostigma leptopodum injection is prepared from a dicranostigma leptopodum extracting solution which is an active drug, and the dicranostigma leptopodum extracting solution is obtained by extracting through alcohol extraction and water precipitation, eluting and purifying through a resin column, and finally adding auxiliary materials. By the dicranostigma leptopodum injection, the blood glucose level of mice can be reduced remarkably, and further experiments show that by acupoint injection of the dicranostigma leptopodum injection, diabetic foot can be treated remarkably.

The invention provides a traditional Chinese medicine acupoint slow-release injection for treating porcine diarrhea, and belongs to the field of traditional Chinese medicines for animals. The invention aims to adopt a traditional Chinese medicine theory to develop the traditional Chinese medicine acupoint slow-release injection which is used for treating porcine diarrhea, performs a long-acting slow-release function with an acupoint injection therapy and can reduce dosing frequency. The traditional Chinese medicine acupoint slow-release injection is prepared from effective components in parts by weight as follows: origanum oil, patchouli oil and poloxamer. The traditional Chinese medicine acupoint slow-release injection is prepared to solve the problems of conventional acupoint injection. The injection is a traditional Chinese medicine preparation, has a long-acting slow-release function, reduces dosing frequency, increases the cure rate, reduces the treatment cost, does not generate drug-resistance bacteria, meanwhile, reduces stress of pigs and saves the labor cost.

The invention relates to the field of medicine, in particular to an acupoint injection for treating cerebral infarction and its application. The active ingredients of the acupoint injection are repaglinide and cilostazol, wherein the weight ratio of repaglinide and cilostazol is 1:20-1:40. The acupoint injection is preferably fat emulsion, and the preferred pharmaceutical excipients are glycerin, lecithin, soybean oil, poloxamer 188 and water for injection. The acupoint injection has the effect of improving the infarct size and nerve score of the experimental animal model when administered through the acupoint injection route, and has the potential to be used for the treatment of cerebral infarction.